Arthur D. Levinson

Who is Arthur D. Levinson?

Arthur Levinson became chairman and chief executive officer of

Genentech in July 1995. Levinson was appointed a member of the board of

directors that same year and was named chairman of the board in 1999.

Levinson

joined the company in 1980 as a senior scientist and subsequently held

the position of staff scientist and director of Cell Genetics at

Genentech. He became vice president of Research Technology in 1989,

vice president of Research in 1990, senior vice president of Research

in 1992, and senior vice president of Research and Development in 1993.

He has been a member of Genentech's executive committee since 1990.

Prior to his employment with Genentech, Levinson was a postdoctoral

fellow in the department of microbiology at the University of

California, San Francisco.

During his career, Levinson

has served on the editorial boards of Molecular Biology and Medicine,

Molecular and Cellular Biology, The Journal of Virology, and Virology.

He also served on the boards of the Pharmaceutical Research and

Manufacturers of America, the Biotechnology Industry Organization, and

the California Healthcare Institute. Levinson has authored or

co-authored more than 80 scientific articles and has been a named

inventor on 11 United States patents, including inventions in the

research of production of recombinant proteins.

Levinson is

a member of the American Society of Microbiology and the American

Society for Biochemistry and Molecular Biology. Levinson sits on the

board of scientific consultants for the Memorial Sloan-Kettering Cancer

Center and is a member of the advisory councils for the California

Institute for Quantitative Biomedical Research (QB3), the Princeton

University Department of Molecular Biology, and the Lewis-Sigler

Institute for Integrative Genomics, also at Princeton. He also serves

on the board of the Technology Network.

Levinson serves on the corporate boards of Apple Inc. and Google Inc.

Levinson

received the Irvington Institute's 1999 Corporate Leadership Award in

Science and was honored the same year with the Corporate Leadership

Award from the National Breast Cancer Coalition.